Modified tau thwarts aggregation in neurodegenerative disease—while retaining its biological function

A designer version of the tau protein, developed by a team led by UT Southwestern Medical Center researchers, maintains its ...
Medscape

GLP-1 Drugs Eyed as Tool to Address Alcohol Use Disorder

Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

Monoclonal antibody shows promising results for rare liver disease

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an ...
Morning Overview on MSN

This rare mutation destroys brain cells, scientists found the cause

Scientists have traced a devastating pattern of brain cell loss in a handful of families to a single, ultra-rare mutation ...